Daño hepático inducido por dronedarona. Descripción de un caso clínico

Guzmán Ramos, María Isabel; Romero García, Teresa; Márquez Saavedra, Esther; Suárez García, Emilio; Martínez Castillo, Rubén.
Gastroenterol. hepatol. (Ed. impr.) ; 41(10): 636-638, dic. 2018. ilus, graf
Artigo Espanhol | IBECS (Espanha) | ID: ibc-178235

Documentos relacionados

  1. Population pharmacokinetic/pharmacodynamic modeling of nifekalant injection with varies dosing plan in Chinese volunteers: a randomized, blind, placebo-controlled study.
  2. Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations.
  3. Antiarrhythmic Drug Therapy: Where Do We Go From Here?
  4. Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis.
  5. MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia.
  6. [Chinese consensus on the use of antiarrhythmic drugs for rhythm control in atrial fibrillation].
  7. Mechanisms Underlying the Antiarrhythmic Action of Compound ALM-802.
  8. Evaluation of Clinical Course and Maintenance Drug Treatment of Supraventricular Tachycardia in Children During the First Years of Life. A Cohort Study from Eastern Germany.
  9. A frightening giant QRS complex in a 3-months-old infant.
  10. A comprehensive protocol combining in vivo and ex vivo electrophysiological experiments in an arrhythmogenic animal model.